RECURSION PHARMACEUTICALS IN

Ticker: RXRX CUSIP: 75629V104 Class: Common Stock

VOLORIDGE INVESTMENT MANAGEMENT, LLC's Holding History (CIK: 0001556921)

Note: Option positions (PUT/CALL) are excluded.

Q2 2025

Shares 359,434 Value ($000) $1,819 Avg Close $4.91 Range $3.79 - $6.11

Q3 2024

Shares 973,583 Value ($000) $6,416 Avg Close $7.17 Range $5.88 - $8.73

Q1 2024

Shares 660,969 Value ($000) $6,590 Avg Close $11.14 Range $8.68 - $15.74

Q4 2023

Shares 584,955 Value ($000) $5,768 Avg Close $7.13 Range $4.97 - $11.17

Q3 2023

Shares 854,395 Value ($000) $6,536 Avg Close $9.98 Range $6.44 - $16.75

Q1 2023

Shares 50,834 Value ($000) $339 Avg Close $7.93 Range $6.40 - $9.73

Q2 2022

Shares 55,266 Value ($000) $450 Avg Close $6.69 Range $4.92 - $9.40

Q1 2022

Shares 327,635 Value ($000) $2,346 Avg Close $10.63 Range $5.80 - $18.23

Q4 2021

Shares 377,717 Value ($000) $6,470 Avg Close $18.82 Range $15.25 - $23.86

Period	Shares	Value ($000)	Average Close	Price Range
Q2 2025	359,434	$1,819	$4.91	$3.79 - $6.11
Q3 2024	973,583	$6,416	$7.17	$5.88 - $8.73
Q1 2024	660,969	$6,590	$11.14	$8.68 - $15.74
Q4 2023	584,955	$5,768	$7.13	$4.97 - $11.17
Q3 2023	854,395	$6,536	$9.98	$6.44 - $16.75
Q1 2023	50,834	$339	$7.93	$6.40 - $9.73
Q2 2022	55,266	$450	$6.69	$4.92 - $9.40
Q1 2022	327,635	$2,346	$10.63	$5.80 - $18.23
Q4 2021	377,717	$6,470	$18.82	$15.25 - $23.86